contract manufacturing

Pharma Tech Industries Honored by Large Pharma Company

Pharma Tech Industries (PTI) has been selected as the Best Overall Supplier by one of the world’s five largest pharmaceutical companies. A pharmaceutical contract manufacturer and packager of powder products, PTI is one of 67 contract manufacturing organizations in the company’s supplier network.

Tapemark Acquiring Iontophoretic Technology

Tapemark has agreed to acquire the iontoPatch business from Travanti Pharma Inc., a wholly owned subsidiary of Teikoku Pharma USA Inc. The iontoPatch product line along with iontophoretic technology for use in medical devices and cosmetics will be marketed under the Travanti Medical name.

Pharma Tech Industries Names Senior Quality Director

Pharma Tech Industries (PTI), a pharmaceutical contract manufacturer and packager of powder products, has hired Preston Wright as its new Senior Director of Quality. Wright will direct all aspects of PTI’s Corporate Quality System, including Quality Assurance, Quality Control, and Quality Operations, at the company’s two contract manufacturing plant locations in Royston, GA, and Union, MO, respectively.

Catalent Pharma Solutions Facility Celebrates 50th

Catalent Pharma Solutions is celebrating the 50th anniversary of its Schorndorf, Germany, facility specializing in modified release technologies and clinical supply services.

Pat Mork Promoted to VP, Human Resources

Tapemark (West St. Paul, MN) is pleased to announce the promotion of Pat Mork to vice president, human resources. In her previous role as director of human resources, she was responsible for the successful oversight in the application of over $750,000 of training for Tapemark employees, supported by a three-year Minnesota Job Skills Partnership grant. Additionally Pat led the establishment of an employee-driven wellness committee that is having a significant impact on the overall health of the Tapemark employee population.

Tapemark Gains Registration For Controlled Substances Manufacturing

Tapemark (West St. Paul, MN) announced it is now DEA registered as a Schedule III – V Manufacturer of Controlled Substances. The Drug Enforcement Administration granted the registration following a successful inspection. It is effective immediately.

Syndicate content